acquired
Stage
About
Allcyte is a biotech spin-off from CeMM that performs functional drug testing on fresh primary human cancer tissue using a high-content imaging platform called Pharmacoscopy to support drug discovery and precision/precision-medicine research. The company was acquired by Exscientia in 2021.
Explore Allcyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.